Found 26 matching trials
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
PHASE2Recent studies of conventional chemotherapy for infants with high-risk hema...
Location
St. Jude Children's Research Hospital
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
PHASE2Blood and marrow stem cell transplant has improved the outcome for patients...
Location
St. Jude Children's Research Hospital
TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders
PHASE2The purpose of this study is to investigate the safety and efficacy of TCRα...
Location
Cincinnati Children's Hospital Medical Center
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
NAThe purpose of the CliniMACS® TCRαβ-Biotin System and CliniMACS® CD19 is to...
Location
Lucile Packard Children's Hospital
CD34+ Selected ASCT for Aggressive Lymphomas
PHASE2Primary objective:
To assess the differences in the overall survival at 3 ...
Location
Department for Medical Oncology; University Hospital/Inselspital
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
PHASE2In this trial, we aim to improve the outcomes of haplo cord transplant. Hap...
Location
University of Chicago Medical Center
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
PHASE2This is a phase II trial designed to test the safety and efficacy (disease ...
Location
Masonic Cancer Center, University of Minnesota
Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT
PHASE1Evaluate the safety of natural killer (NK) cell infusion using CD56 monoclo...
Location
Duke University Health System
Stem Cell Transplantation for Children Affected With Osteopetrosis
NAMalignant infantile osteopetrosis (MIOP) is a rare fatal genetic disorder t...
Location
St. Jude Children's Research Hospital
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
PHASE1The purpose of this study is to learn more about the effects of (classifica...
Location
Columbia University Irving Medical Center